OESOPHAGEAL INTRAMURAL HAEMATOMA

OESOPHAGEAL INTRAMURAL HAEMATOMA was reported 105 times

OESOPHAGEAL INTRAMURAL HAEMATOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 8 0.0021
1 alpha-1 Adrenergic Agonist [EPC] 7 0.0016
2 P2Y12 Platelet Inhibitor [EPC] 43 0.0004
3 Antihypoglycemic Agent [EPC] 1 0.0002
4 General Anesthetic [EPC] 10 0.0002
5 Platelet Aggregation Inhibitor [EPC] 54 0.0001
6 GLP-2 Analog [EPC] 1 0.0001
7 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
8 Nitrate Vasodilator [EPC] 5 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
10 Human Immunoglobulin G [EPC] 1 0.0000
11 Nonsteroidal Anti-inflammatory Drug [EPC] 53 0.0000
12 Factor Xa Inhibitor [EPC] 11 0.0000
13 Angiotensin Converting Enzyme Inhibitor [EPC] 5 0.0000
14 Opioid Agonist [EPC] 9 0.0000
15 Penem Antibacterial [EPC] 1 0.0000
16 BCL-2 Inhibitor [EPC] 1 0.0000
17 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
18 Cardiac Glycoside [EPC] 1 0.0000
19 Proton Pump Inhibitor [EPC] 8 0.0000
20 Androgen Receptor Inhibitor [EPC] 1 0.0000
21 Alkylating Drug [EPC] 3 0.0000
22 Catecholamine [EPC] 1 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
24 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
25 Fluoroquinolone Antibacterial [EPC] 1 0.0000
26 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
27 alpha-Adrenergic Blocker [EPC] 1 0.0000
28 Azole Antifungal [EPC] 1 0.0000
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
35 Corticosteroid [EPC] 4 0.0000
36 Insulin Analog [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000